Answer
Women of childbearing potential and men with female partners of childbearing potential should use effective contraception throughout tucatinib treatment and for at least one week after treatment.
Sources for this answer
- TUKYSA 50 mg film-coated tabletPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 5Document updated
Sources checked